Children’s National Specialists Share Best Practice in Pediatric Care at Arab Health Congress 2012
January 26, 2012
Dubai —Key leaders from Children’s National Medical Center and the Sheikh Zayed Institute for Pediatric Surgical Innovation are participating in this year’s Arab Health exhibition & congress, Dubai, UAE. Children’s National President and CEO Kurt D. Newman, MD, spoke at the Arab Health ‘Leaders in Healthcare’ conference. Dr. Newman shared how Children’s National is experiencing the positive impacts of focusing four integrated initiatives: quality, safety, service excellence/customer service, and access to care, around one central theme: doing what’s best for the children and families cared for by the medical center.
Dr. Newman said: “The UAE has proven to be a vital hub for knowledge sharing in the field of health care. Arab Health presents a great opportunity for both Children’s National and its Sheikh Zayed Institute to join our global colleagues in the discussion of how to re-imagine that field. We hope to use this forum to make creative connections that will build innovative, unconventional, and globally applicable ways of designing and delivering better health care to all people, no matter where they live.”
Two other pediatric experts from Children’s National participated in key discussions at the 5th Middle East Paediatrics Conference, also held during Arab Health.
Peter Kim, MD, PhD, Vice President of The Sheikh Zayed Institute for Pediatric Surgical Innovation and Associate Surgeon-in-Chief, Children’s National Medical Center, highlighted the importance of integrating research and education into the design of a healthcare system to improve clinical treatment and patient care in a sustainable way.
Marshall Summar, MD, Chief of the Division of Genetics and Metabolism, discussed the latest developments in the use of technological innovation in genetics for pediatric health care. His presentation shed light on these innovative developments, citing specific examples from his team’s work on genetic testing and diagnosis in children. He outlined how the development of new technologies in biochemistry, DNA microarrays, and genetic sequencing have greatly expanded the diagnostic reach and scope of genetics beyond classic rare diseases.